Health
New tool can provide non-invasive decision support for NSCLC treatment – News-Medical.net
Personalized treatment options for patients with lung cancer have come a long way in the past two decades.
Reviewed by Emily Henderson, B.Sc.Oct 16 2020
Personalized treatment options for patients with lung cancer have come a long way in the past two decades. For patients with non-small cell lung cancer, the most common subtype of lung cancer and the leading cause of cancer-related death worldwide, two major treatment strategies have emerged: tyrosine kinase inhibitors and immune checkpoint inhibitors. However, choosing the right therapy for a non-small cell lung cancer patient isn’t always an easy …
-
General24 hours agoOf saints and sinners | The Spectator Australia
-
Noosa News15 hours agoTully Sugar Mill celebrates 100 years of cane harvesting amid floods and cyclones
-
General24 hours agoChina and Philippines trade blame over latest South China Sea clash
-
Noosa News13 hours agoFlatmates of missing teen Pheobe Bishop, 17, identified